Vericel Corp (VCEL)

• Market cap: $1.97B
• 1 day: 0.49%
• 5 days: 11.64%
• 1 month: 17.61%
• 3 months: 7.72%
• 6 months: -3.78%
• Year to date: -29.34%
• 1 year: -22.17%
• 5 years: 61.04%
• 10 years: 1,772.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357